BD., Merck KGaA and Bio-Rad Laboratories, Inc. are dominating the market for Global Flow Cytometry Market in 2018

BD:

BD was founded in 1897, and is headquartered at New Jersey; U.S. BD is engaged with the development, manufacture of medical devices, laboratory equipment, diagnostic healthcare for pharmaceutical company, clinical laboratories and others. BD operates its business through two business segments BD Medical and BD Life Sciences. The company has its United States, Europe, Greater Asia and others. The subsidiary of the company is Discovery Labware Inc.(U.S.), Nippon Becton Dickinson Co. Ltd. (Japan), Stanford University (U.S.), Cellular Research, Inc. (California), Becton Dickinson Canada Inc (Canada), , PreAnalytiX GmbH (Switzerland) and others.

  • In April 2018, BD (U.S.) announced the launch of the BD FACSymphony S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform leverages the high parameter capabilities of the BD FACSymphony cell analyzer, giving researchers the ability to sort cell populations to better understand cell phenotypes for immunology and multi-omics research. This product launch has expanded their product line.
  • In July 2017, BD (U.S.) announced the U.S. FDA approval of BD FACSLyric flow cytometer system, an easy-to-use in vitro diagnostic (IVD) system, for use with BD Multitest assays for immunological assessment of individuals and patients having or suspected of having immune deficiency.

Access Full Report at : https://databridgemarketresearch.com/reports/global-flow-cytometry-market/

Merck KGaA:

Merck KGaA was founded in 1668, and headquarter is located at Darmstadt, Germany. Merck KGaA is engaged to develop and manufacture medicines used to treat cancer, multiple sclerosis, and infertility, providing scientists with laboratory materials, technologies and services and develops specialty chemicals and materials for demanding applications. The company operates its business through the healthcare, life science and performance materials. The company has it presence in Europe, North America, Asia-Pacific (APAC), Latin America, Middle East and Africa (MEA) and various subsidiaries as Merck Millipore (U.S.), MERCK, S.L.U. (Spain), Merck and Cie Schaffhausen (Switzerland), Merck, S.A. de C.V.(Mexico), EMD Finance LLC (U.S) and others..

  • In April 2018, Merck KGaA (Germany) launched its new Cell Stream benchtop flow cytometry system which is a compressed, customizable flow cytometer that use a camera for detection. It is a unique optics system and design provides researchers with unparalleled sensitivity and flexibility when analyzing cells and submicron particles. With this launch of the product company has expanded their product line in flow cytometers.
  • In May 2016, Merck KGaA (Germany) has expanded their flow cytometry line Guava flow cytometers to include a high-power modulated green laser. With this expansion the company has upgraded their product line.

Bio-Rad Laboratories, Inc.:

Bio-Rad Laboratories, Inc. was founded in the year of 1952 and it is headquartered in California, U.S. Bio-Rad Laboratories, Inc. focuses towards the manufacturing and suppling life sciences research, healthcare, analytical chemistry which is used to analyze, identify and purify the chemical components. The company majorly operates its business through two different segments Life Science and Clinical Diagnostics. It operates its business in Europe, Pacific Rim, United States and Others.

  • In February 2016, Bio-Rad Laboratories, Inc. (U.S.), has acquired the high performance analytical flow cytometer platform from Propel Labs (U.S.). This agreement will lead the use of advanced multi parameter flow cytometers to the researchers and chemists.
  • In February 2014, Bio-Rad Laboratories, Inc. (U.S.), announced the launch of its ReadiLink antibody labeling kits, one of the market’s simplest antibody conjugation solution for labeling microscale amounts (50–100 µg) of antibody. These kits are ideal for researchers interested in labelling their own antibodies for flow cytometry and cell sorting applications

Market Developments:

  • In May 2018, ACEA Biosciences (California), launch its newly range of cytometer NovoCyte Quanteon flow cytometer with 4 lasers and 25-color option. With the continue launches of benchtop flow cytometers ACEA Biosciences (California) has made a record in innovation of flow cytometry..
  • In July 2018, Biomérieux SA (France) had an agreement with Sysmex Corporation (Japan), for diagnostic analyzers.
  • In April 2018, BD (U.S.) announced the launch of the BD FACSymphony S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform leverages the high parameter capabilities of the BD FACSymphony cell analyzer, giving researchers the ability to sort cell populations to better understand cell phenotypes for immunology and multi-omics research. This product launch has expanded their product line.In September 2018, ELEKTA AB (Sweden), inaugurated new global flow cytometry innovation center in U.K. This inauguration of the oncology campus will help company to enhance their business which design and manufactures radiation therapy technologies.
  • In April 2018, Merck KGaA (Germany) launched its new Cell Stream benchtop flow cytometry system which is a compressed, customizable flow cytometer that use a camera for detection. It is a unique optics system and design provides researchers with unparalleled sensitivity and flexibility when analyzing cells and submicron particles. With this launch of the product company has expanded their product line in flow cytometers.
  • In September 2017, Beckman Coulter, Inc. (U.S.), has launch their first flow cytometry CytoFLEX LX for the cancer researchers which has the visible spectrum in a standard configuration. From this launch of the product they have expanded their business in flow cytometry.